Eye medical device study

Two clinical studies around an Optos medical device have been published.

The first showed the optomap had 30 per cent better capability for detecting retinal lesions over traditional eye exams.

A follow-on study found 56 per cent of patients showed evidence of changes in retinal periphery using the Scottish device. CEO Roy Davis said more research into the retina's periphery and centre was needed.